PIN23 Economic Analysis of Atazanavir as 1st Line Treatment for VIH Patients, on Stable and Sever Health State

Value in Health - United Kingdom
doi 10.1016/j.jval.2012.08.1090
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P1.16-07 Cost-Effectiveness of Pembrolizumab as 1st Line Treatment for Metastatic NSCLC Patients With High PD-L1 Expression in Singapore

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Nystatin-Neomycin-Polymyxin B Combination: Efficacy and Tolerance as 1st-Line Local Treatment of Infectious Vaginitis

Open Journal of Obstetrics and Gynecology
2014English

Pin23 - Clinical and Economic Burden of Invasive Meningococcal Disease in France

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Psy100 - Cost-Effectiveness Analysis of Second Line Treatment for Patients With Ulcerative Colitis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

State-Sponsored Health Insurance and State Economic and Employment Growth

Politics and Policy
SociologyInternational RelationsPolitical Science
2016English

Outcome of Eribulin as a Late Treatment Line for Thai Metastatic Breast Cancer Patients

OncoTargets and Therapy
OncologyPharmacology
2018English

External Validation of the Bilirubin–Atazanavir Nomogram for Assessment of Atazanavir Plasma Exposure in HIV-1-Infected Patients

AAPS Journal
Pharmaceutical Science
2012English

Hypothyroidism Presenting as Sever Icthyosis and Acanthosis Nigricans

Journal of Medical Science And clinical Research
2017English

Pms54 - Cost-Effectiveness Analysis of Etanercept as First Line of Treatment in Colombian Patients With Psoriatic Arthritis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy